← SynDRA
PLIXORAFENIB
SynDRA canonical compound SYN0039864 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | BRAF |
|---|
| Mechanism of action | serine/threonine kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- BRAF INHIBITOR
- Serine/threonine-protein kinase B-raf inhibitor
- serine/threonine kinase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- Plx-8394
- FORE-8394
- FORE8394
- PLX8394
- Plx8394
- PLX 8394
- FORE 8394
- J2L7Z273SG
- RefChem:174942
- BRAF Inhibitor PLX8394
- BRAF Inhibitor FORE8394
- PL-8394
- plixorafenib [INN]
- Plixorafenib (USAN/INN)
- PLIXORAFENIB [USAN]
- UNII-J2L7Z273SG
- GTPL9131
- orb1304039
- C25H21F3N6O3S
- SCHEMBL15666953
- SCHEMBL29368914
- PLX 8394 [WHO-DD]
- BDBM317826
- GLXC-23285
- EX-A1461
- MFCD29472263
- NSC797932
- NSC801007
- s7965
- AKOS030526478
- CS-5123
- EBC-221113
- NSC-797932
- NSC-801007
- US9624213, Compound P-0338
- NCGC00483921-01
- AC-36850
- BP168493
- BS-15485
Look up PLIXORAFENIB in the interactive SynDRA portal →